C
Cosmas Rinaldi Adithya Lesmana
Researcher at University of Indonesia
Publications - 28
Citations - 2221
Cosmas Rinaldi Adithya Lesmana is an academic researcher from University of Indonesia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 14 publications receiving 1487 citations.
Papers
More filters
Journal ArticleDOI
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata,Ann-Lii Cheng,Norihiro Kokudo,Masatoshi Kudo,Jeong Min Lee,Jidong Jia,Ryosuke Tateishi,Kwang Hyub Han,Yoghesh K. Chawla,Shuichiro Shiina,Wasim Jafri,Diana A. Payawal,Takamasa Ohki,Sadahisa Ogasawara,Pei-Jer Chen,Cosmas Rinaldi Adithya Lesmana,Laurentius A. Lesmana,Rino Alvani Gani,Shuntaro Obi,A. Kadir Dokmeci,Shiv Kumar Sarin +20 more
TL;DR: The latest guidelines for the treatment of HCC recommend evidence-based management and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.
Journal ArticleDOI
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata,Tatsuo Kanda,Lai Wei,Ming-Lung Yu,Wang-Long Chuang,Alaaeldin Ibrahim,Cosmas Rinaldi Adithya Lesmana,Jose D. Sollano,Manoj Kumar,Ankur Jindal,Barjesh Chander Sharma,Saeed Hamid,A. Kadir Dokmeci,Mamun-Al-Mahtab,G.W. McCaughan,Jafri Wasim,Darrell H. G. Crawford,Jia-Horng Kao,Osamu Yokosuka,George K. K. Lau,Shiv Kumar Sarin +20 more
TL;DR: Recommendations on treatment of hepatitis C are presented in this review after an international working party gathered at Istanbul Congress Center, Istanbul, Turkey on 13 March 2015.
Journal ArticleDOI
Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study
Cosmas Rinaldi Adithya Lesmana,Levina S. Pakasi,Sri Inggriani,Maria L. Aidawati,Laurentius A. Lesmana +4 more
TL;DR: Bivariate analyses found associations among fatty pancreas and several risk factors such as gender, age, systolic and diastolic blood pressures, body mass index (BMI), fasting plasma glucose (FPG), triglycerides (TG) and cholesterol levels.
Journal ArticleDOI
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.
Grace Lai-Hung Wong,Vincent Wai-Sun Wong,Alexander J. Thompson,Jidong Jia,Jinlin Hou,Cosmas Rinaldi Adithya Lesmana,Adityo Susilo,Yasuhito Tanaka,Wah-Kheong Chan,E.J. Gane,Arlinking K. Ong-Go,Seng Gee Lim,Sang Hoon Ahn,Ming-Lung Yu,Teerha Piratvisuth,Henry Lik-Yuen Chan +15 more
TL;DR: Clinical scenarios covering the use of pharmacological treatment for COVID-19 in the case of liver derangement, and assessment and management of patients with chronic hepatitis B or hepatitis C, non-alcoholic fatty liver disease, liver cirrhosis, and liver transplantation during the pandemic are discussed.
Journal ArticleDOI
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Masao Omata,Tatsuo Kanda,Lai Wei,Ming-Lung Yu,Wang-Long Chuang,Alaaeldin Ibrahim,Cosmas Rinaldi Adithya Lesmana,Jose D. Sollano,Manoj Kumar,Ankur Jindal,Barjesh Chander Sharma,Saeed Hamid,A. Kadir Dokmeci,Mamun Al-Mahtab,G.W. McCaughan,Jafri Wasim,Darrell H. G. Crawford,Jia-Horng Kao,Osamu Yokosuka,George K. K. Lau,Shiv Kumar Sarin +20 more
TL;DR: The finalized recommendations for hepatitis C prevention, epidemiology, and laboratory testing are presented in this review.